Cholesterol metabolic reprogramming mediates microglia-induced chronic neuroinflammation and hinders neurorestoration

Qiang Zhao1, Jiajian Li1, Jingjing Feng1

  • 1Department of Neurology, Xuanwu Hospital Capital Medical University, National Center for Neurological Disorders, Beijing, China.

Nature Metabolism
|September 23, 2025
PubMed

Insights

Stroke recovery is hindered by chronic neuroinflammation. This study reveals that microglial cholesterol accumulation drives this inflammation, and targeting cholesterol metabolism promotes brain repair and functional recovery in mice.

Area of Science:

  • Neuroscience
  • Immunology
  • Metabolism

Background:

  • Chronic neuroinflammation significantly impedes recovery after stroke.
  • The precise mechanisms linking sustained microglial activation and cholesterol metabolism post-stroke remain unclear.

Purpose of the Study:

  • To investigate the role of microglial cholesterol metabolism in chronic neuroinflammation after ischemic injury.
  • To explore therapeutic strategies targeting microglial cholesterol overload for stroke recovery.

Main Methods:

  • Single-cell RNA sequencing to identify stroke-associated microglial clusters.
  • Intracerebral infusion of free cholesterol or cholesterol crystals to model sustained microglial activation.
  • Genetic and pharmacological activation of CYP46A1 in male mice.

Main Results:

  • Ischemic injury leads to persistent microglial activation, cholesterol accumulation, and metabolic reprogramming.
  • Distinct foamy microglia clusters exhibit significant alterations in cholesterol metabolism pathways.
  • Aberrant cholesterol metabolism directly correlates with prolonged neuroinflammatory responses.
  • Reducing microglial cholesterol overload via CYP46A1 activation enhanced white matter repair and functional recovery in male mice.

Conclusions:

  • Microglial cholesterol metabolism is a critical factor driving chronic neuroinflammation post-stroke.
  • Targeting microglial cholesterol metabolism presents a promising therapeutic avenue for mitigating long-term brain damage and improving stroke outcomes.